erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Osteitis D010000 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Osteolysis D010014 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Sakushima A et al. Guaiacylglycerol-7'-O-methyl 8'-vanillic acid ether and related compounds from Boreava orientalis. Phytochem Anal pmid:12597255
Thomaidou E et al. Perioperative Use of Erythromycin Reduces Cognitive Decline After Coronary Artery Bypass Grafting Surgery: A Pilot Study. Clin Neuropharmacol pmid:28816833
Ghoreishi SM et al. Effect of orally administered cisapride, bethanechol, and erythromycin on the apparent efficiency of colostral IgG absorption in neonatal Holstein-Friesian calves. J. Vet. Intern. Med. pmid:25641234
pmid:5110814
Yokohori N et al. Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA). Intern. Med. pmid:28050003
Bottega A et al. Evaluation of constitutive and inducible resistance to clindamycin in clinical samples of Staphylococcus aureus from a tertiary hospital. Rev. Soc. Bras. Med. Trop. pmid:25467260
pmid:16888699
pmid:17760348
Zhou W et al. Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China. Indian J Med Microbiol pmid:25008823
Abraham T and Sistla S Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications. Indian J Med Microbiol pmid:30084408
Cai C et al. Effects of erythromycin on γ-glutamyl cysteine synthetase and interleukin-1β in hyperoxia-exposed lung tissue of premature newborn rats. J Pediatr (Rio J) pmid:24878007
pmid:
Enyuan Q et al. Erythromycin combined with corticosteroid reduced inflammation and modified trauma-induced tracheal stenosis in a rabbit model. Ther Adv Respir Dis pmid:29781361
Cao T et al. Anti-pruritic efficacies of doxycycline and erythromycin in the treatment of acne vulgaris: A randomized single-blinded pilot study. Indian J Dermatol Venereol Leprol pmid:29770785
Pranteda G et al. Pitted keratolysis, erythromycin, and hyperhidrosis. Dermatol Ther pmid:24703267
Wang X et al. Phenotypic and molecular characterization of Streptococcus agalactiae colonized in Chinese pregnant women: predominance of ST19/III and ST17/III. Res. Microbiol. pmid:29378338
Yayan J and Rasche K Growing Antibiotic Resistance in Fatal Cases of Staphylococcal Pneumonia in the Elderly. Adv. Exp. Med. Biol. pmid:26747068
Alvarez-Sánchez M et al. [Bacterial resistance in acne? A meta-analysis of the controversy]. Cir Cir pmid:26738649
Mondragón-Navarro M et al. Potential association between erythromycin and cholestatic hepatitis. Med Intensiva pmid:26707838
Thomas J et al. Residents'corner October 2015. DeRmpath&Clinic: Acute generalised exanthematous pustulosis. Eur J Dermatol pmid:26693641
Albayrak A et al. A case of bacillary angiomatosis developed at a burn site. Indian J Dermatol Venereol Leprol pmid:22199082
Gencoglan G et al. Therapeutic hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther pmid:20415827
Jahansepas A et al. Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants. Microb. Drug Resist. pmid:28525287
Silva V et al. Genetic Characterization of vanA-Enterococcus faecium Isolates from Wild Red-Legged Partridges in Portugal. Microb. Drug Resist. pmid:28504889
McCutcheon K and Manga P An antibiotic recipe for an arrhythmic disaster. Cardiovasc J Afr pmid:26592910
Commerford PJ From the Editor's Desk. Cardiovasc J Afr pmid:26592903
Fallahpour N et al. Overproduction of Erythromycin by Ultraviolet Mutagenesis and Expression of ermE Gene in Saccharopolyspora erythraea. Assay Drug Dev Technol pmid:29120674
HAIGHT TH and FINLAND M The antibacterial action of erythromycin. 1952 Proc. Soc. Exp. Biol. Med. pmid:13047351
VANNUCCHI V [Clinical study of a new antibiotic; erythromycin]. 1952 Riv Crit Clin Med pmid:13056483
ERYTHROMYCIN. 1952 Br Med J pmid:12987755
ANDERSON RC et al. The toxicity and distribution of ilotycin. 1952 J Am Pharm Assoc Am Pharm Assoc pmid:12999613
ERYTHROMYCIN, new and promising antibiotic. 1952 N. Engl. J. Med. pmid:14947939
HAIGHT TH and FINLAND M Laboratory and clinical studies on erythromycin. 1952 N. Engl. J. Med. pmid:14947931
ERYTHROMYCIN: another antibiotic. 1952 Lancet pmid:14939901
CRONK GA and NAUMANN DE Ilotycin (erythromycin) for fusospirochetal infections of the oro-pharynx; a progress report. 1953 J Lancet pmid:13221896
VELEZ MORAN C [Experience with erythromycin in the Hospital de Aislamiento de Guayaquil]. 1953 Rev Ecuat Hig Med Trop pmid:13237604
AUSTRIAN R and ROSENBLUM R The relative efficacy of erythromycin (ilotycin) and of penicillin in the treatment of pneumococcal lobar pneumonia. 1953 Am. J. Med. Sci. pmid:13104398
LIVINGOOD CS et al. Erythromycin in local treatment of cutaneous bacterial infections. 1953 J Am Med Assoc pmid:13108585
RUIZ SANCHEZ F et al. [Clinical experiences with carbomycin and erythromycin]. 1953 Medicina (Mex) pmid:13110596
SCHONBERG IL The treatment of pyogenic skin infections with ilotycin ointment (erythromycin). 1953 Ohio Med pmid:13111755
MARTIN WJ et al. The present status of erythromycin. 1953 Proc Staff Meet Mayo Clin pmid:13112261
PERLMAN D Colorimetric method for determination of aureomycin, carbomycin, erythromycin, and terramycin in aqueous solution. 1953 Science pmid:13113207
TALLEY RW Clinical evaluation of erythromycin. 1953 South. Med. J. pmid:13113414
HEDENIUS P and TUNEVALL HG [Erythromycin, its antibacterial effect in vitro, its absorption and excretion, with a preliminary report on a series of cases with erythromycin therapy]. 1953 Sven Lakartidn pmid:13113605
LEVADITI C et al. [Erythromycin; new antibiotic derived from Streptomyces erythreus]. 1953 Ann Inst Pasteur (Paris) pmid:13148738
PARIS J [Severe recurrent intestinal infection due to pathogenic Staphylococcus aureus treated with various antibiotics; favorable effect of erythromycin]. 1953 Arch Mal Appar Dig Mal Nutr pmid:13149270
[Erythromycin, a new antibiotic]. 1953 Dia Med pmid:13083424
KIRBY WM et al. Erythromycin serum concentrations following administration in acid-resistant tablets. 1953 Antibiot Chemother (Northfield) pmid:24542409
JONES PN et al. Use of antibiotics in nonbacterial respiratory infections. 1953 J Am Med Assoc pmid:13084382
KIRSHBAUM A et al. A cupplate method for the determination of erythromycin concentrations in serum and other body fluids. 1953 Antibiot Chemother (Northfield) pmid:24542421
ROMANSKY MJ Current trends in antibiotic therapy. 1953 Med Bull US Army Eur pmid:13085979
CLARK RK The chemistry of erythromycin. I. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542535
FABRE J [A new antibiotic: erythromycin; its therapeutic effect in 60 cases of various diseases]. 1953 Praxis pmid:13088584
MAPLE FM et al. Serum concentrations of erythromycin following intravenous administration. 1953 Antibiot Chemother (Northfield) pmid:24542586
BUNN PA and COOK E Treatment of pneumococcal pneumonia with erythromycin and carbomycin (magnamycin). 1953 AMA Arch Intern Med pmid:13091455
LEE CC et al. Tissue distribution of erythromycin in rats. 1953 Antibiot Chemother (Northfield) pmid:24542649
KIRBY WM et al. Treatment of staphylococcic infections with erythromycin. 1953 AMA Arch Intern Med pmid:13091463
SYLVESTER JC and JOSSELYN LE Absorption of erythromycin. II. Erythromycin stearate. 1953 Antibiot Chemother (Northfield) pmid:24542651
BACON AE Erythromycin in the treatment of pneumococcal pneumonia. 1953 Del Med J pmid:13094978
GRIGSBY ME et al. Some laboratory and clinical experiences with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542704
RUIZ SANCHEZ F et al. [Erythromycin in the treatment of diarrheas due to Micrococcus pyogenes]. 1953 Medicina (Mex) pmid:13098728
HASBROUCK RB and GARVEN FC The chemistry of erythromycin. II. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542706
DIPHTHERIA carriers rapidly cleared. 1953 Whats New pmid:24542774
PYODERMA responds to erythromycin ointment. 1953 Whats New pmid:24542848
DORE R [Basal metabolism; significance and interpretation]. 1953 Union Med Can pmid:13122881
ANDERSON EA Cure of resistant meningococcemia with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542853
DEARING WH Micrococcic (staphylococcic) enteritis as a complication of antibiotic therapy; its response to erythromycin. 1953 Proc Staff Meet Mayo Clin pmid:13037897
NEW antibiotic. 1953 South. Med. J. pmid:13038549
FREEMAN LC and SCOTT RB Erythromycin in treatment of pyoderma in children. 1953 J. Pediatr. pmid:13053367
NESERKE EI Clinical report on the new antibiotic, erythromycin. 1953 J. Am. Vet. Med. Assoc. pmid:13061363
GABLE GR et al. Treatment of gonorrhea with erythromycin. 1953 Am J Syph Gonorrhea Vener Dis pmid:13065617
HERRELL WE et al. Erythromycin for infections due to Micrococcus pyogenes. 1953 J Am Med Assoc pmid:13069224
ROBINSON HM and ZELIGMAN I Erythromycin ointment in the treatment of the pyodermas. 1953 J. Invest. Dermatol. pmid:13069824
ROBINSON HM and COHEN MM Treatment of granuloma inguinale with erythromycin. 1953 J. Invest. Dermatol. pmid:13069825
SUPNIEWSKI J [Erythromycin]. 1953 Pol Tyg Lek (Wars) pmid:13073602
MATHIEU DE FOSSEY B [A new antibiotic: erythromycin]. 1953 Presse Med pmid:13074126
FLIPPIN HF and FOLTZ EL The newer antimicrobial agents. 1953 Am Pract Dig Treat pmid:13080581
BAZAN C et al. [Treatment of whooping cough with erythromycin]. 1953 Rev Chil Pediatr pmid:13134787
BRICAIRE H and DE FOSSEY B [Two new antibiotics: erythromycin and soframycin]. 1953 Rev Prat pmid:13135190
LUND E [Erythromycin, a new antibiotic]. 1953 Ugeskr. Laeg. pmid:13136562
HINSHAW HC The treatment of infectious diseases: advances in the use of antimicrobial drugs. 1953 Calif Med pmid:13094538
MCCOWEN MC et al. The effects of erythromycin (ilotycin, lilly) against certain parasitic organisms. 1953 Am. J. Trop. Med. Hyg. pmid:13040654
LUND E Erythromycin; a new antibiotic. 1953 Acta Pathol Microbiol Scand pmid:13138191
VANNUCCHI V [Ilotycin sulfa: association of ilotycin with a trisulfonamide]. 1953 Riv Crit Clin Med pmid:14358369
DE GENNES L et al. [Erythromycin treatment of four infections]. 1953 Apr 17-24 Bull Mem Soc Med Hop Paris pmid:13066998
RAVINA A et al. [Some observations on erythromycin treatment]. 1953 May 15-22 Bull Mem Soc Med Hop Paris pmid:13067012
[Erythromycin (ilotycin)]. 1953 May 2-9 Clin Nuova Rass Prog Med Int pmid:13116428
PANNARALE MR [Effect of erythromycin on the epithelial inclusions (Halbertstaedter and Prowazek bodies) of the trachomatous conjunctiva]. 1953 Sep-Nov Boll. Soc. Ital. Biol. Sper. pmid:13140753
PARADISO M and BORGHERESI S [Erythromycin]. 1954 Riv Clin Pediatr pmid:13195449
HAIGHT TH et al. Efficacy of erythromycin in the treatment of acute respiratory infections. 1954 U S Armed Forces Med J pmid:13196235
LYONS RE et al. Treatment of bacterial infections of the skin with erythromycin-neomycin ointment. 1954 U S Armed Forces Med J pmid:13196237
LOWBURY EJ and CASON JS Aureomycin and erythromycin therapy for str. pyogenes in burns. 1954 Br Med J pmid:13199343
MULLINS JF Neomycin-erythromycin ointment in the treatment of pyodermas. 1954 Tex State J Med pmid:13169049
CHANCEY RL and MEIKLEJOHN GA Treatment of influenza with erythromycin. 1954 U S Armed Forces Med J pmid:13169449
PARROTT FD et al. Staphylococcal bacteremia: report of a case successfully treated with erythromycin. 1954 Am Pract Dig Treat pmid:13171526
GIBSON CD et al. The treatment of bacterial pneumonia with erythromycin: a controlled clinical study. 1954 Ann. Intern. Med. pmid:13171794
DENNIG H and LIEWALD HJ [Erythromycin as a new antibiotic]. 1954 Dtsch. Med. Wochenschr. pmid:13173221
SHOEMAKER EH and YOW EM Clinical evaluation of erythromycin. 1954 AMA Arch Intern Med pmid:13123564
WASHBURN WH The infrared determination of erythromycin. 1954 J Am Pharm Assoc Am Pharm Assoc (Baltim) pmid:13129106
CRONK GA and NAUMANN DE Ilotycin (erythromycin) in the treatment of A prime influenza. 1954 N Y State J Med pmid:13133098